Recent Updates
Recently added Catalysts
IDYA

IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy R and IDE397 Combination in MTAP Deletion Bladder Cancer

Monday, December 4, 2023 1 min read
Key Takeaway: IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy R and IDE397 Combination in MTAP Deletion Bladder Cancer

Full Press Release Details

IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy R and IDE397 Combination in MTAP Deletion Bladder Cancer.
Tags: IDYA Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Dec 4, 2023